We can't find the internet
Attempting to reconnect
16639.1 PFLS-LS
Assessment of a drug candidate for the treatment of two rare orphan diseases: Morquio type B disease and GM1 gangliosidosis
Résumé
Assessment of a drug candidate for the treatment of two rare orphan diseases: Morquio type B disease and GM1 gangliosidosis
Textes supplémentaires
Abstract
Morquio type B disease and GM1 gangliosidosis are two rare orphan genetic disorders caused by mutated forms of the enzyme beta-galactosidase. A selective beta-galactosidase inhibitor was identified as a potential rescuer of the mutated enzyme as it helps the folding of the enzyme in vitro. The current project proposes to synthesize this potent drug with improved routing, to measure its efficacy on patient cells and to assess its in vivo bioavailability.
Participants
Julie Charollais-Thoenig
Wirtschaftspartner
charollais@dorphan.com
Dorphan SA CHE-407.871.618 Julie Charollais-Thoenig Chemin de l'Eglise 7 1066 Epalinges VD CH
Roger Marti
Kontaktperson
roger.marti@hefr.ch
HEIA-FR Haute Ecole d'ingénierie et d'archi de Fribourg Roger Marti Boulevard de Pérolles 80 1700 Fribourg FR CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2014-07-31
- Date de fin
- 2015-11-30
- Coûts totaux approuvés
- CHF 156225.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T115 Medical technology 100.0%